1. Home
  2. APRE vs RVP Comparison

APRE vs RVP Comparison

Compare APRE & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • RVP
  • Stock Information
  • Founded
  • APRE 2006
  • RVP 1994
  • Country
  • APRE United States
  • RVP United States
  • Employees
  • APRE N/A
  • RVP N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • RVP Medical/Dental Instruments
  • Sector
  • APRE Health Care
  • RVP Health Care
  • Exchange
  • APRE Nasdaq
  • RVP Nasdaq
  • Market Cap
  • APRE 21.2M
  • RVP 18.6M
  • IPO Year
  • APRE 2019
  • RVP 2001
  • Fundamental
  • Price
  • APRE $2.62
  • RVP $0.85
  • Analyst Decision
  • APRE Strong Buy
  • RVP
  • Analyst Count
  • APRE 2
  • RVP 0
  • Target Price
  • APRE $15.50
  • RVP N/A
  • AVG Volume (30 Days)
  • APRE 35.9K
  • RVP 68.1K
  • Earning Date
  • APRE 03-25-2025
  • RVP 03-28-2025
  • Dividend Yield
  • APRE N/A
  • RVP N/A
  • EPS Growth
  • APRE N/A
  • RVP N/A
  • EPS
  • APRE N/A
  • RVP N/A
  • Revenue
  • APRE $1,310,839.00
  • RVP $38,265,097.00
  • Revenue This Year
  • APRE $134.21
  • RVP N/A
  • Revenue Next Year
  • APRE N/A
  • RVP N/A
  • P/E Ratio
  • APRE N/A
  • RVP N/A
  • Revenue Growth
  • APRE 130.31
  • RVP N/A
  • 52 Week Low
  • APRE $2.15
  • RVP $0.56
  • 52 Week High
  • APRE $8.85
  • RVP $1.34
  • Technical
  • Relative Strength Index (RSI)
  • APRE 30.05
  • RVP 61.26
  • Support Level
  • APRE $2.59
  • RVP $0.77
  • Resistance Level
  • APRE $3.72
  • RVP $0.82
  • Average True Range (ATR)
  • APRE 0.35
  • RVP 0.04
  • MACD
  • APRE -0.13
  • RVP -0.00
  • Stochastic Oscillator
  • APRE 1.41
  • RVP 69.16

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: